SANOFI US SERVICES INC. for SANOFI US SERVICES INC
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
Issues related to Intellectual Property; issues related to March-In; and issues related to S.150 "Affordable Prescriptions for Patients Act".
Foreign entity interest: Sanofi US Services Inc is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CLAIRE WILLIS BRANDEWIE | — |
| JENNIFER DALE | — |
| KATIE OPPENHEIM | — |
Manufacturing MAN
Issues related to supply chain; issues related to RSV; issues related to Type 1 Diabetes; issues related to Pharmacy Benefit Managers (PBMs); issues related to Vaccines; issues related to Taxes; and issues related to over-the-counter.
Foreign entity interest: Sanofi US Services Inc is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MORGAN BRADLEY-JONES | — |
| CLAIRE WILLIS BRANDEWIE | — |
| KATIE OPPENHEIM | — |
| AMY L REDL | — |
Health Issues HCR
Issues related to prescription-to- over the counter switch; issues related to influenza vaccines; issues related to 340B; issues related to Respiratory Syncytial Virus (RSV) access; issues related to RSV Immunizations; general issues related to vaccines; issues related to clinical trial diversity; general issues related to drug pricing; issues related to out of pocket (OOP); general issues to insulin pricing; issues related to HR 5376 "Inflation Reduction Act"; issues related to Additional Condition for Prescription Use (ACNU); issues related to copay accumulators; issues related to HR3656 "Vaccine Access Improvement Act"; issues related to Vaccine Issues Compensation Program (VICP); issues related to HR 830 "HELP Copays Act"; issues related to Pandemic and All-Hazards Preparedness Act (PAHPA)reauthorization; issues related to HR 1503 "Prescription Information Modernization Act of 2023"; general issues related FDA; issues related to FDA Drug Development; issues related to Pharmacy Benefit Managers (PBMs); issues related to insurance design; issues related to S. 1542 "DRUG Act"; issues related to S. 1375 "HELP Copays Act"; issues related to tax credits; issues related to S. 1339 "PBM Reform Act"; issues related to delinking; issues related to HR 2880 "Protecting Patients Against PBM Abuse Act"; issues related to Type 1 Diabetes screening; issues related to pandemic preparedness; issues related to intellectual property; issues related to Transplant; issues related HR 5339 and S. 3131 "Orphan Cures Act"; Rare Pediatric Priority Review Voucher Program related to HR 7834 "Creating Hope Reauthorization Act of 2024"; Orphan Drug Negotiation within HR5378 "Inflation Reduction Act"; issues related to drug price negotiations; issues related to COPD Research funding; Biologic/Small Molecule drug negotiation eligibility within HR7174 "EPIC Act"; CDC Type 1 Diabetes Awareness and Education with LHHS appropriations; issues related to HR 8698 and S.4504 "SCREEN for Type 1 Diabetes"; issues related to HRSA - Type 1 Diabetes Screening; general issues related to Inflation Reduction Act; issues related to March-In rights; and issues related to Routine Immunizations Rates.
Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MORGAN BRADLEY-JONES | — |
| CLAIRE WILLIS BRANDEWIE | — |
| JENNIFER DALE | — |
| KATIE OPPENHEIM | — |
| AMY L REDL | — |
Medicare/Medicaid MMM
Issues related to Medicare Negotiations; issues related to 340B; and issues related to Medicaid Drug Rebate Program rule.
Foreign entity interest: Sanofi US Services Inc is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CLAIRE WILLIS BRANDEWIE | — |
| JENNIFER DALE | — |
| KATIE OPPENHEIM | — |
| AMY L REDL | — |
Trade (domestic/foreign) TRD
Issues related to WTO Trips Waiver; issues related to Trade; issues related to Importation; issues related to Insulin; issues related to Transplant; and issues related to Supply Chain.
Foreign entity interest: Sanofi US Services Inc is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MORGAN BRADLEY-JONES | — |
| CLAIRE WILLIS BRANDEWIE | — |
| JENNIFER DALE | — |
| KATIE OPPENHEIM | — |
Taxation/Internal Revenue Code TAX
General issues related to Taxes; issues related to Vaccine Injury Compensation Program (VICP); issues related to HR 3656 (117th) Vaccine Access Improvement Act; issues related to supply chain; and issues related to TRIP Waivers.
Foreign entity interest: Sanofi US Services Inc is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MORGAN BRADLEY-JONES | — |
| CLAIRE WILLIS BRANDEWIE | — |
| JENNIFER DALE | — |
| KATIE OPPENHEIM | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.